1096 related articles for article (PubMed ID: 30306351)
21. Transgender health and the impact of aging and menopause.
Cheung AS; Nolan BJ; Zwickl S
Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
[TBL] [Abstract][Full Text] [Related]
22. [Gender identities in transition].
Strittmatter E; Holtmann M
Z Kinder Jugendpsychiatr Psychother; 2020; 48(2):93-102. PubMed ID: 32162593
[TBL] [Abstract][Full Text] [Related]
23. Adult development and quality of life of transgender and gender nonconforming people.
Bockting W; Coleman E; Deutsch MB; Guillamon A; Meyer I; Meyer W; Reisner S; Sevelius J; Ettner R
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):188-97. PubMed ID: 26835800
[TBL] [Abstract][Full Text] [Related]
24. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
25. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
26. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
Green AE; DeChants JP; Price MN; Davis CK
J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
[TBL] [Abstract][Full Text] [Related]
27. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
28. Drug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals.
Cirrincione LR; Senneker T; Scarsi K; Tseng A
Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):565-582. PubMed ID: 32479127
[TBL] [Abstract][Full Text] [Related]
29. SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.
Fisher AD; Senofonte G; Cocchetti C; Guercio G; Lingiardi V; Meriggiola MC; Mosconi M; Motta G; Ristori J; Speranza AM; Pierdominici M; Maggi M; Corona G; Lombardo F
J Endocrinol Invest; 2022 Mar; 45(3):657-673. PubMed ID: 34677807
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Gender-Affirming Hormones on Gender Dysphoria, Quality of Life, and Psychological Functioning in Transgender Individuals: A Systematic Review.
van Leerdam TR; Zajac JD; Cheung AS
Transgend Health; 2023 Feb; 8(1):6-21. PubMed ID: 36895312
[TBL] [Abstract][Full Text] [Related]
31. A European Network for the Investigation of Gender Incongruence in adolescents.
Boogers LS; Wiepjes CM; Staphorsius AS; Klink DT; Ciancia S; Romani A; Stolk THR; van den Boogaard E; Steensma TD; de Vries ALC; van Trotsenburg ASP; den Heijer M; Fisher AD; Cools M; Hannema SE
J Sex Med; 2024 Mar; 21(4):350-356. PubMed ID: 38427555
[TBL] [Abstract][Full Text] [Related]
32. Clinical and sociodemographic characteristics as predictors for quality of life in transmasculine and transfeminine individuals receiving gender-affirming hormone therapy.
Lad SU; Sinopoli J; Khong B; Conroy B; Perzynski AT; Del Rincon JP
Soc Sci Med; 2024 Apr; 346():116734. PubMed ID: 38490912
[TBL] [Abstract][Full Text] [Related]
33. An Intersectional Approach to Therapy with Transgender Adolescents and Their Families.
Golden RL; Oransky M
Arch Sex Behav; 2019 Oct; 48(7):2011-2025. PubMed ID: 30604170
[TBL] [Abstract][Full Text] [Related]
34. [Medical management of transgender children and adolescents].
Castilla-Peón MF
Bol Med Hosp Infant Mex; 2018; 75(1):7-14. PubMed ID: 29652872
[TBL] [Abstract][Full Text] [Related]
35. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
36. Transgender and gender nonconforming adolescent care: psychosocial and medical considerations.
Guss C; Shumer D; Katz-Wise SL
Curr Opin Pediatr; 2015 Aug; 27(4):421-6. PubMed ID: 26087416
[TBL] [Abstract][Full Text] [Related]
37. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
39. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
[TBL] [Abstract][Full Text] [Related]
40. The psychologist's role in transgender-specific care with U.S. veterans.
Johnson L; Shipherd J; Walton HM
Psychol Serv; 2016 Feb; 13(1):69-76. PubMed ID: 25961643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
